EH
NVO

Equitable Holdings’s Novo Nordisk NVO Stock Holding History

Equitable Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.11M Sell
43,172
-1,117
-3% -$52.9K 0.01% 700
2025
Q4 		$2.25M Sell
44,289
-4,649
-9% -$238K 0.02% 598
2025
Q3 		$2.72M Sell
48,938
-792
-2% -$46.4K 0.02% 512
2025
Q2 		$3.43M Sell
49,730
-1,687
-3% -$115K 0.03% 421
2025
Q1 		$3.57M Buy
51,417
+141
+0.3% +$11.6K 0.03% 369
2024
Q4 		$4.41M Sell
51,276
-24,843
-33% -$2.69M 0.04% 309
2024
Q3 		$9.06M Buy
76,119
+13,117
+21% +$1.75M 0.09% 188
2024
Q2 		$8.99M Buy
63,002
+7,973
+14% +$1.06M 0.09% 173
2024
Q1 		$7.07M Buy
55,029
+25,057
+84% +$2.98M 0.08% 187
2023
Q4 		$3.1M Buy
29,972
+17,681
+144% +$1.75M 0.04% 304
2023
Q3 		$1.12M Buy
12,291
+2,271
+23% +$200K 0.02% 515
2023
Q2 		$811K Buy
10,020
+6,326
+171% +$517K 0.01% 576
2023
Q1 		$294K Buy
+3,694
New +$262K ﹤0.01% 804

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Equitable Holdings's NVO Position: Q1 2026 in Review

Equitable Holdings reduced its Novo Nordisk (NVO) stake by 2.5% in Q1 2026, selling an estimated $52.9K and leaving 43,172 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #700.

Equitable Holdings first reported a position in NVO in Q1 2023 and has held it in 13 quarters since. The position peaked at $9.06M in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Equitable Holdings held 43,172 shares of Novo Nordisk worth $2.11M as of Q1 2026.
  • Equitable Holdings sold 1,117 Novo Nordisk shares in Q1 2026, an estimated $52.9K.
  • Novo Nordisk made up 0.01% of Equitable Holdings's portfolio in Q1 2026, its #700 holding.
  • Equitable Holdings first reported a position in Novo Nordisk in Q1 2023 and has held it in 13 quarters since.
  • Equitable Holdings's Novo Nordisk position peaked at $9.06M in Q3 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.